Mac2a treatment2
isolate
not applicable
age
not applicable
biomaterial_provider
not applicable
collection_date
2023-10-16
geo_loc_name
not applicable
sex
male
tissue
skin
cell_line
Mac2a
cell_type
T cells
disease
T-cell lymphoma
treatment
Navitoclax, Venetoclax, Ruxolitinib, DMSO
BioSampleModel
Human